Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea?
Abstract
:1. Introduction
2. Etiology of IBS
3. Visceral Hypersensitivity
4. Immune Activation in IBS
5. The Adenosine A2B Receptor
6. Intestinal Fluid Secretion
7. Release of 5-HT from Enterochromaffin Cells
8. Colonic Motility
9. Modulation of the Inflammatory Response
10. Anti-Nociceptive Actions
11. Conclusions and Remarks
Conflicts of Interest
References
- Chang, L.; Lembo, A.; Sultan, S. American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome. Gastroenterology 2014, 147, 1149–1172. [Google Scholar] [CrossRef] [PubMed]
- Ford, A.C.; Lacy, B.E.; Talley, N.J. Irritable bowel syndrome. N. Engl. J. Med. 2017, 376, 2566–2578. [Google Scholar] [CrossRef] [PubMed]
- Mearin, F.; Lacy, B.E.; Chang, L.; Chey, W.D.; Lembo, A.J.; Simren, M.; Spiller, R. Bowel disorders. Gastroenterology 2016. [Google Scholar] [CrossRef]
- Canavan, C.; West, J.; Card, T. Review article: The economic impact of the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2014, 40, 1023–1034. [Google Scholar] [CrossRef] [PubMed]
- Fukudo, S.; Kinoshita, Y.; Okumura, T.; Ida, M.; Akiho, H.; Nakashima, Y.; Nishida, A.; Haruma, K. Ramosetron reduces symptoms of irritable bowel syndrome with diarrhea and improves quality of life in women. Gastroenterology 2016, 150, 358–366. [Google Scholar] [CrossRef] [PubMed]
- Lacy, B.E. Emerging treatments in neurogastroenterology: Eluxadoline—A new therapeutic option for diarrhea-predominant IBS. Neurogastroenterol. Motil. 2016, 28, 26–35. [Google Scholar] [CrossRef] [PubMed]
- Menees, S.B.; Maneerattannaporn, M.; Kim, H.M.; Chey, W.D. The efficacy and safety of rifaximin for the irritable bowel syndrome: A systematic review and meta-analysis. Am. J. Gastroenterol. 2012, 107, 28–35. [Google Scholar] [CrossRef] [PubMed]
- Camilleri, M. Pharmacological agents currently in clinical trials for disorders in neurogastroenterology. J. Clin. Investig. 2013, 123, 4111–4120. [Google Scholar] [CrossRef] [PubMed]
- Drossman, D.A. Functional gastrointestinal disorders: History, pathophysiology, clinical features and Rome IV. Gastroenterology 2016, 150, 1262–1279. [Google Scholar] [CrossRef] [PubMed]
- Keszthelyi, D.; Troost, F.J.; Masclee, A.A. Irritable bowel syndrome: Methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303, G141–G154. [Google Scholar] [CrossRef] [PubMed]
- Akbar, A.; Walters, J.R.; Ghosh, S. Review article: Visceral hypersensitivity in irritable bowel syndrome: Molecular mechanisms and therapeutic agents. Aliment. Pharmacol. Ther. 2009, 30, 423–435. [Google Scholar] [CrossRef] [PubMed]
- Matricon, J.; Meleine, M.; Gelot, A.; Piche, T.; Dapoigny, M.; Muller, E.; Ardid, D. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2012, 36, 1009–1031. [Google Scholar] [CrossRef] [PubMed]
- Bueno, L.; Fioramonti, J. Effects of inflammatory mediators on gut sensitivity. Can. J. Gastroenterol. 1999, 13 (Suppl. A), 42A–46A. [Google Scholar] [CrossRef] [PubMed]
- Antonioli, L.; Fornai, M.; Colucci, R.; Ghisu, N.; Tuccori, M.; Del Tacca, M.; Blandizzi, C. Regulation of enteric functions by adenosine: Pathophysiological and pharmacological implications. Pharmacol. Ther. 2008, 120, 233–253. [Google Scholar] [CrossRef] [PubMed]
- Feoktistov, I.; Biaggioni, I. Adenosine A2B receptors. Pharmacol. Rev. 1997, 49, 381–402. [Google Scholar] [PubMed]
- Asano, T.; Tanaka, K.I.; Tada, A.; Shimamura, H.; Tanaka, R.; Maruoka, H.; Takenaga, M.; Mizushima, T. Aminophylline suppresses stress-induced visceral hypersensitivity and defecation in irritable bowel syndrome. Sci. Rep. 2017, 7. [Google Scholar] [CrossRef] [PubMed]
- Wouters, M.M.; Vicario, M.; Santos, J. The role of mast cells in functional GI disorders. Gut 2016, 65, 155–168. [Google Scholar] [CrossRef] [PubMed]
- Demaude, J.; Salvador-Cartier, C.; Fioramonti, J.; Ferrier, L.; Bueno, L. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: Implications for delayed epithelial barrier dysfunction. Gut 2006, 55, 655–661. [Google Scholar] [CrossRef] [PubMed]
- Serna, H.; Porras, M.; Vergara, P. Mast cell stabilizer ketotifen (4-(1-methyl-4-piperidylidene)-4h-benzo(4,5)cyclohepta(1,2-b)thiophen-10(9H)-one fumarate) prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat. J. Pharmacol. Exp. Ther. 2006, 319, 1104–1111. [Google Scholar] [CrossRef] [PubMed]
- Cremon, C.; Gargano, L.; Morselli-Labate, A.M.; Santini, D.; Cogliandro, R.F.; De Giorgio, R.; Stanghellini, V.; Corinaldesi, R.; Barbara, G. Mucosal immune activation in irritable bowel syndrome: Gender-dependence and association with digestive symptoms. Am. J. Gastroenterol. 2009, 104, 392–400. [Google Scholar] [CrossRef] [PubMed]
- Dinan, T.G.; Clarke, G.; Quigley, E.M.; Scott, L.V.; Shanahan, F.; Cryan, J.; Cooney, J.; Keeling, P.W. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: Role of muscarinic receptors. Am. J. Gastroenterol. 2008, 103, 2570–2576. [Google Scholar] [CrossRef] [PubMed]
- Cenac, N.; Andrews, C.N.; Holzhausen, M.; Chapman, K.; Cottrell, G.; Andrade-Gordon, P.; Steinhoff, M.; Barbara, G.; Beck, P.; Bunnett, N.W.; et al. Role for protease activity in visceral pain in irritable bowel syndrome. J. Clin. Investig. 2007, 117, 636–647. [Google Scholar] [CrossRef] [PubMed]
- Hughes, P.A.; Harrington, A.M.; Castro, J.; Liebregts, T.; Adam, B.; Grasby, D.J.; Isaacs, N.J.; Maldeniya, L.; Martin, C.M.; Persson, J.; et al. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes. Gut 2013, 62, 1456–1465. [Google Scholar] [CrossRef] [PubMed]
- Bashashati, M.; Moossavi, S.; Cremon, C.; Barbaro, M.R.; Moraveji, S.; Talmon, G.; Rezaei, N.; Hughes, P.A.; Bian, Z.X.; Choi, C.H.; et al. Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol. Motil. 2017. [Google Scholar] [CrossRef] [PubMed]
- Thabane, M.; Kottachchi, D.T.; Marshall, J.K. Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment. Pharmacol. Ther. 2007, 26, 535–544. [Google Scholar] [CrossRef] [PubMed]
- Spiller, R.; Garsed, K. Infection, inflammation, and the irritable bowel syndrome. Dig. Liver Dis. 2009, 41, 844–849. [Google Scholar] [CrossRef] [PubMed]
- Bashashati, M.; Moradi, M.; Sarosiek, I. Interleukin-6 in irritable bowel syndrome: A systematic review and meta-analysis of IL-6 (-g174c) and circulating IL-6 levels. Cytokine 2017, 99, 132–138. [Google Scholar] [CrossRef] [PubMed]
- Lam, C.; Tan, W.; Leighton, M.; Hastings, M.; Lingaya, M.; Falcone, Y.; Zhou, X.; Xu, L.; Whorwell, P.; Walls, A.F.; et al. A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). Gut 2016, 65, 91–99. [Google Scholar] [CrossRef] [PubMed]
- Barbara, G.; Wang, B.; Stanghellini, V.; de Giorgio, R.; Cremon, C.; Di Nardo, G.; Trevisani, M.; Campi, B.; Geppetti, P.; Tonini, M.; et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007, 132, 26–37. [Google Scholar] [CrossRef] [PubMed]
- Wouters, M.M.; Balemans, D.; Van Wanrooy, S.; Dooley, J.; Cibert-Goton, V.; Alpizar, Y.A.; Valdez-Morales, E.E.; Nasser, Y.; Van Veldhoven, P.P.; Vanbrabant, W.; et al. Histamine receptor H1-mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome. Gastroenterology 2016, 150, 875–887. [Google Scholar] [CrossRef] [PubMed]
- Klooker, T.K.; Braak, B.; Koopman, K.E.; Welting, O.; Wouters, M.M.; van der Heide, S.; Schemann, M.; Bischoff, S.C.; van den Wijngaard, R.M.; Boeckxstaens, G.E. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010, 59, 1213–1221. [Google Scholar] [CrossRef] [PubMed]
- Aherne, C.M.; Kewley, E.M.; Eltzschig, H.K. The resurgence of A2B adenosine receptor signaling. Biochim. Biophys. Acta 2011, 1808, 1329–1339. [Google Scholar] [CrossRef] [PubMed]
- Kolachala, V.L.; Obertone, T.S.; Wang, L.; Merlin, D.; Sitaraman, S.V. Adenosine 2b receptor (A2B R) signals through adenylate cyclase (AC) 6 isoform in the intestinal epithelial cells. Biochim. Biophys. Acta 2006, 1760, 1102–1108. [Google Scholar] [CrossRef] [PubMed]
- Feoktistov, I.; Biaggioni, I. Role of adenosine A(2B) receptors in inflammation. Adv. Pharmacol. 2011, 61, 115–144. [Google Scholar] [PubMed]
- Haskó, G.; Csóka, B.; Németh, Z.H.; Vizi, E.S.; Pacher, P. A2B adenosine receptors in immunity and inflammation. Trends Immunol. 2009, 30, 263–270. [Google Scholar] [CrossRef] [PubMed]
- Strohmeier, G.R.; Reppert, S.M.; Lencer, W.I.; Madara, J.L. The A2B adenosine receptor mediates camp responses to adenosine receptor agonists in human intestinal epithelia. J. Biol. Chem. 1995, 270, 2387–2394. [Google Scholar] [CrossRef] [PubMed]
- Chandrasekharan, B.P.; Kolachala, V.L.; Dalmasso, G.; Merlin, D.; Ravid, K.; Sitaraman, S.V.; Srinivasan, S. Adenosine 2B receptors (A2BAR) on enteric neurons regulate murine distal colonic motility. FASEB J. 2009, 23, 2727–2734. [Google Scholar] [CrossRef] [PubMed]
- Weissmuller, T.; Campbell, E.L.; Rosenberger, P.; Scully, M.; Beck, P.L.; Furuta, G.T.; Colgan, S.P. PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J. Clin. Investig. 2008, 118, 3682–3692. [Google Scholar] [CrossRef] [PubMed]
- Crane, J.K.; Olson, R.A.; Jones, H.M.; Duffey, M.E. Release of ATP during host cell killing by enteropathogenic E. coli and its role as a secretory mediator. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283, G74–G86. [Google Scholar] [CrossRef] [PubMed]
- Warren, C.A.; Li, Y.; Calabrese, G.M.; Freire, R.S.; Zaja-Milatovic, S.; van Opstal, E.; Figler, R.A.; Linden, J.; Guerrant, R.L. Contribution of adenosine A2B receptors in Clostridium difficile intoxication and infection. Infect. Immun. 2012, 80, 4463–4473. [Google Scholar] [CrossRef] [PubMed]
- Chin, A.; Svejda, B.; Gustafsson, B.I.; Granlund, A.B.; Sandvik, A.K.; Timberlake, A.; Sumpio, B.; Pfragner, R.; Modlin, I.M.; Kidd, M. The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302, G397–G405. [Google Scholar] [CrossRef] [PubMed]
- Christofi, F.L. Purinergic receptors and gastrointestinal secretomotor function. Purinergic Signal. 2008, 4, 213–236. [Google Scholar] [CrossRef] [PubMed]
- Linan-Rico, A.; Ochoa-Cortes, F.; Beyder, A.; Soghomonyan, S.; Zuleta-Alarcon, A.; Coppola, V.; Christofi, F.L. Mechanosensory signaling in enterochromaffin cells and 5-HT release: Potential implications for gut inflammation. Front. Neurosci. 2016, 10, 564. [Google Scholar] [CrossRef] [PubMed]
- Christofi, F.L.; Zhang, H.; Yu, J.G.; Guzman, J.; Xue, J.; Kim, M.; Wang, Y.Z.; Cooke, H.J. Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system. J. Comp. Neurol. 2001, 439, 46–64. [Google Scholar] [CrossRef] [PubMed]
- Antonioli, L.; Fornai, M.; Awwad, O.; Giustarini, G.; Pellegrini, C.; Tuccori, M.; Caputi, V.; Qesari, M.; Castagliuolo, I.; Brun, P.; et al. Role of the A2B receptor–adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats. Br. J. Pharmacol. 2014, 171, 1314–1329. [Google Scholar] [CrossRef] [PubMed]
- Kolachala, V.L.; Vijay-Kumar, M.; Dalmasso, G.; Yang, D.; Linden, J.; Wang, L.; Gewirtz, A.; Ravid, K.; Merlin, D.; Sitaraman, S.V. A2B adenosine receptor gene deletion attenuates murine colitis. Gastroenterology 2008, 135, 861–870. [Google Scholar] [CrossRef] [PubMed]
- Kolachala, V.; Ruble, B.; Vijay-Kumar, M.; Wang, L.; Mwangi, S.; Figler, H.; Figler, R.; Srinivasan, S.; Gewirtz, A.; Linden, J.; et al. Blockade of adenosine A2B receptors ameliorates murine colitis. Br. J. Pharmacol. 2008, 155, 127–137. [Google Scholar] [CrossRef] [PubMed]
- Aherne, C.M.; Saeedi, B.; Collins, C.B.; Masterson, J.C.; McNamee, E.N.; Perrenoud, L.; Rapp, C.R.; Curtis, V.F.; Bayless, A.; Fletcher, A.; et al. Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis. Mucosal Immunol. 2015, 8, 1324–1338. [Google Scholar] [CrossRef] [PubMed]
- Frick, J.S.; MacManus, C.F.; Scully, M.; Glover, L.E.; Eltzschig, H.K.; Colgan, S.P. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J. Immunol. 2009, 182, 4957–4964. [Google Scholar] [CrossRef] [PubMed]
- Cushley, M.J.; Tattersfield, A.E.; Holgate, S.T. Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Am. Rev. Respir. Dis. 1984, 129, 380–384. [Google Scholar] [PubMed]
- Feoktistov, I.; Biaggioni, I. Adenosine A2B receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J. Clin. Investig. 1995, 96, 1979–1986. [Google Scholar] [CrossRef] [PubMed]
- Ryzhov, S.; Zaynagetdinov, R.; Goldstein, A.E.; Novitskiy, S.V.; Dikov, M.M.; Blackburn, M.R.; Biaggioni, I.; Feoktistov, I. Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells. J. Immunol. 2008, 180, 7212–7220. [Google Scholar] [CrossRef] [PubMed]
- Ryzhov, S.; Goldstein, A.E.; Matafonov, A.; Zeng, D.; Biaggioni, I.; Feoktistov, I. Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: An A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J. Immunol. 2004, 172, 7726–7733. [Google Scholar] [CrossRef] [PubMed]
- Hua, X.; Kovarova, M.; Chason, K.D.; Nguyen, M.; Koller, B.H.; Tilley, S.L. Enhanced mast cell activation in mice deficient in the A2B adenosine receptor. J. Exp. Med. 2007, 204, 117–128. [Google Scholar] [CrossRef] [PubMed]
- Yang, D.; Zhang, Y.; Nguyen, H.G.; Koupenova, M.; Chauhan, A.K.; Makitalo, M.; Jones, M.R.; St Hilaire, C.; Seldin, D.C.; Toselli, P.; et al. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J. Clin. Investig. 2006, 116, 1913–1923. [Google Scholar] [CrossRef] [PubMed]
- Bilkei-Gorzo, A.; Abo-Salem, O.M.; Hayallah, A.M.; Michel, K.; Muller, C.E.; Zimmer, A. Adenosine receptor subtype-selective antagonists in inflammation and hyperalgesia. Naunyn-Schmiedebergs Arch. Pharmacol. 2008, 377, 65–76. [Google Scholar] [CrossRef] [PubMed]
- Abo-Salem, O.M.; Hayallah, A.M.; Bilkei-Gorzo, A.; Filipek, B.; Zimmer, A.; Muller, C.E. Antinociceptive effects of novel A2B adenosine receptor antagonists. J. Pharmacol. Exp. Ther. 2004, 308, 358–366. [Google Scholar] [CrossRef] [PubMed]
- Hu, X.; Adebiyi, M.G.; Luo, J.; Sun, K.; Le, T.T.; Zhang, Y.; Wu, H.; Zhao, S.; Karmouty-Quintana, H.; Liu, H.; et al. Sustained elevated adenosine via ADORA2B promotes chronic pain through neuro-immune interaction. Cell Rep. 2016, 16, 106–119. [Google Scholar] [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Asano, T.; Takenaga, M. Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea? J. Clin. Med. 2017, 6, 104. https://doi.org/10.3390/jcm6110104
Asano T, Takenaga M. Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea? Journal of Clinical Medicine. 2017; 6(11):104. https://doi.org/10.3390/jcm6110104
Chicago/Turabian StyleAsano, Teita, and Mitsuko Takenaga. 2017. "Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea?" Journal of Clinical Medicine 6, no. 11: 104. https://doi.org/10.3390/jcm6110104
APA StyleAsano, T., & Takenaga, M. (2017). Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea? Journal of Clinical Medicine, 6(11), 104. https://doi.org/10.3390/jcm6110104